1-3 of 3
Sanjay Divakaran
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

The Rationale for Combined Proteasome and Autophagy Inhibition in Multiple Myeloma Established Using Novel Translational Platforms

John Paul Y.C. Shen, M.D., Sanjay Divakaran, B.S., Sridevi Ponduru, M.D., Dan T. Vogl, MD, Ravi K. Amaravadi, M.D., James E. Bradner, M.D.
Journal: Blood
Blood (2008) 112 (11): 2755.
https://doi.org/10.1182/blood.V112.11.2755.2755
Published: 2008
Journal Articles

Autophagy as a Target Pathway in Multiple Myeloma: A Forward Chemical Genetic Approach.

John P. Shen, BS, Sanjay Divakaran, Letian Kuai, Ph.D., Xiang Wang, Ph.D., Shao-En Ong, Ph.D., Ravi Amaravadi, M.D., John Wood, Ph.D., Steven Carr, Ph.D., Stuart Schreiber, Ph.D., Stephen Haggarty, Ph.D., James Bradner, M.D.
Journal: Blood
Blood (2007) 110 (11): 2510.
https://doi.org/10.1182/blood.V110.11.2510.2510
Published: 2007
Journal Articles

Discovery and Characterization of Small Molecule Inhibitors of Autophagy for Cancer Therapy.

James E. Bradner, MD, John P. Shen, BS, Ethan O. Perlstein, PhD, Sanjay Divakaran, BS, Edward F. Greenberg, BS, Ravi Amaravadi, MD, Stuart L. Schreiber, PhD
Journal: Blood
Blood (2006) 108 (11): 2606.
https://doi.org/10.1182/blood.V108.11.2606.2606
Published: 2006